You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study

Article info

Article menu
XML
Epidemiology/Health services research
Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study

Authors

  • Junichi Hoshino Nephrology Center, Toranomon Hospital, Tokyo, JapanCommittee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Masanori Abe Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, JapanDivision of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Takayuki Hamano Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, JapanDepartment of Nephrology, Nagoya City University, Nagoya, Japan PubMed articlesGoogle scholar articles
  • Takeshi Hasegawa Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, JapanShowa University Research Administration Center (SURAC); Division of Nephrology, Department of Internal Medicine, Showa University, Shinagawa-ku, Japan PubMed articlesGoogle scholar articles
  • Atsushi Wada Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, JapanKitasaito Hospital, Asahikawa, Japan PubMed articlesGoogle scholar articles
  • Yoshifumi Ubara Nephrology Center, Toranomon Hospital, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Kenmei Takaichi Nephrology Center, Toranomon Hospital, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Shigeru Nakai Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, JapanDepartment of Clinical Engineering, Fujita Health University, Aichi, Japan PubMed articlesGoogle scholar articles
  • Ikuto Masakane Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, JapanYabuki Hospital, Yamagata, Japan PubMed articlesGoogle scholar articles
  • Kosaku Nitta Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, JapanDepartment of Nephrology, Tokyo Women’s Medical University, Tokyo, Japan PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Junichi Hoshino; jhoshino-ind{at}umin.ac.jp
View Full Text

Citation

Hoshino J, Abe M, Hamano T, et al
Glycated albumin and hemoglobin A1c levels and cause-specific mortality by patients’ conditions among hemodialysis patients with diabetes: a 3-year nationwide cohort study
BMJ Open Diabetes Research and Care 2020;8:e001642. doi: 10.1136/bmjdrc-2020-001642

Publication history

  • Received June 3, 2020
  • Revised July 25, 2020
  • Accepted August 4, 2020
  • First published October 23, 2020.
Online issue publication 
June 08, 2021

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.